Community Pharmacy Accreditation Shown to Improve Patient Care, Reduce Medication Error

Few would argue the im-portance of reducing medi-cation errors, and many state boards of pharmacy have made significant inroads to-ward that end. The advent of continuous quality improve-ment (CQI) programs in the community pharmacy set-ting is a tremendous step in the right direction. Inconsis-tency among interpretations, guidelines, and available resources, however, make significant improvements difficult. For this reason, na-tional community pharmacy accreditation seems a likely path to better patient care.

To explore this issue, NABP convened a task force October 28-29, 2008 at its Mount Prospect, IL headquarters. The charge of the task force was to review possible community phar-macy practice accreditation standards and recommend standards for incorporation into a community pharma-

cy accreditation program for use by the boards of pharmacy in their efforts to protect the public health.

This task force came about as a result of the Task Force on Continuous Quality Improvement, Peer Review, and Inspecting for Patient Safety, which recommended in December 2007 that NABP consider establishing a pharmacy accreditation program, in conjunction with the state boards of pharmacy, that will ensure pharmacies are operating in a manner con-sistent with CQI standards, decreasing the occurrence of quality-related events and ultimately increasing patient safety.

A national accreditation program would establish best practices based on proven results that improve pharmacy systems and re-duce errors. Such a program would provide pharmacies

with a benchmark to reach and sustain, and would pro-vide the boards of pharmacy with resources and a system of measurement to ensure that pharmacies in their states maintain appropriate practice and CQI standards. In addition, a national ac-creditation program would assure the public that the practice of pharmacy is taking proactive measures to reduce medication errors and improve patient care.

Upcoming EventsJanuary 20-21, 2009Committee on Law Enforcement/Legislation MeetingNABP HeadquartersMount Prospect, IL

March 9-20, 2009PCOA Administrations

April 7, 2009Committee on Constitution and BylawsConference Call

newsletterNational Association of Boards of Pharmacy®

aid to governmentthe profession

the public1904 to 2008

November-December 2008 / Volume 37 Number 10

In This Issue. . . .Legal Briefs:Wholesale Affirmation: Almost

180

Association News:NABP Takes Steps to Curb Diversion, Pollution Resulting from Improperly Stored, Discarded Medications

183

Association News:NABP Task Force Examines Standard-ization of Medication Container Labels to Aid in Prevention of Errors

185

105th Annual Meeting:Call for Posters: Session Participants to Network, Share Information

187

Feature News:California Legislature Extends Deadline for Implementing Track-and-Trace Technology

189

(continued on page 178)

fromNABP

nabp newsletter

178

QCPP Accredits AU Pharmacies

The concept is by no means a new one. The Pharmacy Guild of Austra-lia, with the assistance of other industry stakeholders, developed the Quality Care Pharmacy Program (QCPP) in 1998. The Guild calls QCPP, which accredits com-munity pharmacies in Aus-tralia, “an important vehicle for industry self-regulation, designed to improve service to customers.” Its primary objective is improved patient care. According to the Guild, “QCPP is ensuring that Community Pharmacy pro-vides a uniformed approach when delivering professional services and customer care.”

Currently, more than 86% of Australian commu-nity pharmacies are accred-ited under QCPP. To ensure that pharmacies are meeting the required standard in all areas of their practice, they are required to undergo an external audit every two years by QCPP licensed assessors. All pharmacies that attain accreditation and remain operational under the program are eligible to receive financial incentives that are administered by Medicare Australia.

CQI Assessment Discussed

Part of the charge of the 2007 NABP task force was to evaluate the need for an assessment tool for use by

boards of pharmacy to evaluate pharmacies in the area of patient safety. Some members of the task force expressed concern with states that have simply written regulations that mandate pharmacies implement CQI programs, stating that such efforts are insufficient. Task force members noted that a major obstacle for some states is a lack of resources for enforcement; some do not have a sufficient number of inspectors to ensure that CQI programs are being correctly and effectively implemented. As a solution, members proposed that an ac-creditation program be implemented by NABP in the community setting similar in some regard to accreditation programs for hospitals.

The task force members agreed that NABP was the optimal entity to explore the possibility of devel-oping and implementing such an accreditation program, in part, because of its proven expertise in accreditation based on the success of the du-rable medical equipment, prosthetics, orthotics, and supplies (DMEPOS), Veri-fied-Accredited Wholesale Distributors® (VAWD®), and Verified Internet Pharmacy Practice Sites™ (VIPPS®) accreditation programs. Additionally, NABP has the ability and experience to address the nuances and intricacies of chain and independent pharmacy practice, as well as appropriate resources

to develop and implement such a program. Further, because of its past and on-going endeavours, NABP will likely be recognized by entities such as the Centers for Medicare and Medicaid Services (CMS) and pharmacy benefit management organiza-tions that may eventu-ally require accreditation. NABP moreover is per-ceived by the public as an independent, trustworthy, safety-oriented organiza-tion.

The task force further recommended that NABP supplement its own expe-rience and resources by seeking additional input from patient safety orga-nizations such as the Insti-tute for Safe Medication Practices (ISMP) to assist in the development of an accreditation program. Based on another recom-mendation of the task force, NABP has developed a CQI program inspection form and pharmacy qual-ity self-audit form, which have been incorporated in the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act), and which are intended to be used proactively and solely for educational purposes.

Accreditation Ties to Reimbursement

CMS developed accredi-tation requirements in 2007 as a means to help ensure that beneficiaries receive the appropriate products, services, and patient care

(continued on page 184)

The NABP Newsletter (ISSN 8756-4483) is published 10 times a year by the National

Association of Boards of Pharmacy (NABP)

to educate, to inform, and to communicate the objectives and programs of the Association and its 66 member boards

of pharmacy to the profession and the

public. The opinions and views expressed in this publication do not necessarily reflect the

official views, opinions, or policies of NABP or any board unless

expressly so stated. The subscription rate is

$35 per year.

National Association of Boards of Pharmacy

1600 Feehanville Drive Mount Prospect, IL

60056 847/391-4406 www.nabp.net

custserv@nabp.net

Carmen A. Catizone Executive Director/

Secretary

Larissa Doucette Communications

Manager

©2008 National Association of Boards

of Pharmacy. All rights reserved. No part of this publication may be reproduced in any manner without the

written permission of the executive director/

secretary of the National Association of

Boards of Pharmacy.

Feature News

Pharmacy Accreditation(continued from page 177)

november-december 2008

179

Executive CommitteeOren M. Peacock, JrChairpersonOne-year term

Rich PalomboPresidentOne-year term

Gary A. Schnabel President-electOne-year term

William T. “Bill” WinsleyTreasurerOne-year term

Karen M. RyleMember, District 1Serving second year of a three-year term

Elizabeth Scott “Scotti” RussellMember, District 2Serving second year of a three-year term

Michael A. BurlesonMember, District 3Serving first year of a three-year term

Gregory Braylock, SrMember, District 4Serving first year of a three-year term

Lloyd K. JessenMember, District 5Serving second year of a three-year term

Malcolm J. BroussardMember, District 6Serving third year of a three-year term

Cathryn J. LewMember, District 7Serving second year of a two-year term

Hal WandMember, District 8Serving first year of a three-year term

NABP Executive Committee elections are held each year at the Association’s Annual Meeting.

Association News

NABP Restores Computerized FPGEE with Increased Security, More Test Sites for Applicants

As advancements in secure testing technol-ogy forge ahead, the push for more electronically based systems and less use of the traditional paper-and-pencil mechanisms continues. With this in mind, NABP will soon be returning the For-eign Pharmacy Graduate Equivalency Examina-tion® (FPGEE®) to a computer-based format, eliminating the paper-and-pencil examination.

The FPGEE is the third computerized examina-tion to be administered by NABP, after the North American Pharmacist Licensure Examination® (NAPLEX®) and the Multistate Pharmacy Jurisprudence Examina-tion® (MPJE®). The new computerized FPGEE will debut at the April 14, 2009 administration.

Like the paper-and-pencil FPGEE, the com-puterized examination will continue to be adminis-tered one day in the spring and one day in the fall; however, instead of limit-ing the available testing locations to three sites, applicants will be able to choose from more than 200 Pearson VUE testing sites located within the continental United States. In addition, it is anticipat-ed that applicants will be able to schedule their test sites electronically 48 to 72 hours after having been ac-cepted to take the FPGEE.

NABP test vendor, Pearson VUE, will admin-ister the computerized FPGEE as it does with the NAPLEX and the MPJE. Demonstrating a record of solid customer service combined with a secure and consistent test center network, Pearson VUE is committed to providing a reliable and professional testing environment for applicants on behalf of NABP.

licensure institutions that present their educa-tional backgrounds and licensure and/or registra-tion to practice pharma-cy. Applicants must also pass the Test of English as a Foreign Language™ (TOEFL®) and the Test of Spoken English™ (TSE®), or the TOEFL Internet-based Test (iBT). The FPGEC certificate allows foreign graduates to partially fulfill eligi-bility requirements for licensure in the 50 United States and the District of Columbia where the cer-tification is recognized.

To prepare for the FPGEE, NABP recom-mends that applicants take the Pre-FPGEE®, the official FPGEE practice examination written and developed by NABP. This practice examination is designed to help familiar-ize applicants with the FPGEE by exhibiting the types of questions provid-ed on the actual examina-tion as well as providing a score estimate.

Additional information on the FPGEE as well as the Pre-FPGEE is avail-able in the Examination Programs section on the NABP Web site at www .nabp.net.

The new computerized FPGEE will debut at the April 14, 2009 administration...applicants will be able to choose from more than 200 Pearson VUE testing sites located within the continental United States.

The FPGEE is one component of the Foreign Pharmacy Graduate Ex-amination Committee™ (FPGEC®) certification process. In addition to passing the examination, FPGEC applicants are required to have certain documents submitted from educational and

nabp newsletter

180

Legal Briefs

Wholesale Affirmation: AlmostBy Dale J. Atkinson, JD

A s the complexities of wholesale distribution of drugs and tracking

pedigrees increases, so do the complexities of litigation. Consider the following:

A wholesale distributor of drugs (licensee A) and its successor (licensee B) li-censed by the Nevada State Board of Pharmacy engaged in the purchase of phar-maceuticals from manu-facturers, wholesalers, and pharmacies and resold such product to other wholesal-ers and pharmacies. The licensees were licensed by the Board in 1998 and, in the case of the successor, in 2002. Where it is not necessary to distinguish between the two entities, they will be referred to col-lectively as licensees. The licensees bought and resold three drugs in particular (Lupron®, Zoladex®, and Serostim®), from, among others, three Florida-based wholesalers. Over a three-year period, the licensees conducted business with a number of questionable en-tities resulting in an investi-gation by the Board.

Certain bulk purchases by licensee A of Serostim from one Florida wholesaler turned out to contain coun-terfeit Serostim. Out of 927 boxes, 399 were counterfeit. Although it represented itself as authorized, the Florida wholesaler was not an authorized distributor of Serostim. Indeed, the Florida wholesaler obtained its Serostim from a supplier

who eventually was impris-oned for operating without a Florida permit.

The licensees made purchases of Lupron and Zoladex at below Wholesale Acquisition Cost (WAC) from Florida entities that falsely represented them-selves as authorized dis-tributors, but in fact were not. The licensees were also accused of substandard record-keeping violations related to both acquisitions and drug pedigrees, includ-ing indications that the licensees were authorized distributors but did not identify from whom they had purchased the drugs. Numerous below WAC purchases were undertaken to the approximate total of $8.5 million.

These activities resulted in a Board investigation and charges that the licensees bought and sold adulterated and misbranded prescrip-tion drugs, failed to make, maintain, and provide accurate pedigrees detailing the sources of the drugs, failed to make, keep, and provide accurate records of their purchases, and purchased drugs from unli-censed distributors. After a five-day hearing, the Board rendered its final order whereby it revoked licensee A’s wholesaler license,

fined it $1,000,000, and assessed $37,609 in costs. As to licensee B, the Board revoked the license, fined it $371,000, and assessed costs of $37,609. After an initial appeal, which remanded the matter on the issues of only fines and costs, the fines against licensee A were reduced to $519,750 and the fines against licensee B were reduced to $31,250. The licensees appealed to the Nevada Supreme Court.

The licensees’ appeal was premised upon many arguments including:

whether the Board had 1. jurisdiction to discipline the licensees;whether the licensees 2. were improperly joined as defendants in the administrative proceed-ings;whether licensees were 3. deprived of due process rights by being denied the right to discovery and a finding of guilty on charges not con-tained in the accusa-tions;whether the correct legal 4. standard and interpreta-tions were applied to the statutes and regulations;whether the Board ac-5. tions were arbitrary and capricious; andwhether the corporate 6. veil was impermissibly pierced by allowing cer-tain employees to bind the licensees.The licensees first ar-

gued that the Board did not have jurisdiction over them

november-december 2008

181

(continued on page 182)

Legal Briefs

Attorney Dale J. Atkinson is a partner in the law firm of Atkinson & Atkinson, outside counsel for NABP.

because all the purchasing and sale activities occurred outside the state of Nevada. In rejecting this argu-ment, the court noted that nothing in the practice acts limits the Board’s review of unprofessional conduct to acts occurring solely in the state of Nevada. Thus, the court found jurisdiction lies with the Board.

Next, the licensees argued that they were improperly joined to-gether at the hearing by the Board because they did not necessarily participate in the same transactions or series of transactions that constituted the alleged of-fenses. The court rejected this argument finding that the evidence showed that licensee B acquired the stock of licensee A, con-ducted its operations at the same facilities, and contin-ued transacting business with vendors after licensee A ended its operations. Further, the court held that neither party established undue prejudice due to the joinder of the two licensees at the hearing. Thus, the court upheld the combined hearing.

The licensees argued that their due process rights had been violated based upon a lack of sufficient notice of the factual basis for the charges, by finding them guilty of charges not listed on the accusations, and by denying them the right to discovery and not providing a list of wit-

nesses. The court quickly disposed of the notice issue finding that the licens-ees received notice of the charges and fully par-ticipated in their defense. Addressing the allegation that the licensees were convicted of charges not listed on the accusation, again the court rejected this defense. The court stated that the charges clearly and unambiguously notified the licensees of the charges, including allegations of in-accurate pedigrees. Finally, regarding the allegations of pre-hearing discovery, the court reaffirmed that there is no constitutional right to discovery in administrative proceedings, nor does Ne-vada law provide for such. Accordingly, the procedural due process arguments of the licensees were rejected.

The licensees also ar-gued several points alleg-ing that the Board erred in determining its conclusions of law. First, the licensees argued that the proceed-ings were “quasi-criminal” because Nevada law pro-vides for the imposition of certain criminal penalties. The court rejected this argument stating that the attorney general or district attorney prosecute criminal matters and that separate Board proceedings do give rise to the application of criminal standards in ad-ministrative proceedings.

As a matter of first impression (those not yet decided by a Nevada court),

the licensees next argued that the prohibition of “[t]he manufacture, sale or delivery, holding or offering for sale of any food, drug, device or cosmetic that is adulterated or misbranded” contains a knowledge requirement, that is that the licensees knew the drugs were adulterated or misbranded. The licensees argued that they were not conscious of any wrongdo-ing insofar as the drugs received and cannot be held responsible under the Ne-vada statute. After assessing the language of the Nevada law, as well as comparing it to the similar language in its federal counterpart, the Federal Food, Drug, and Cosmetic Act, the court re-jected the licensees’ theory and held that a knowledge requirement does not exist and that liability may be imposed absent conscious-ness of any wrongdoing.

Turning its attention to the pedigrees, the licens-ees argued that the Board misinterpreted Nevada law when finding that the licensees did not indicate from whom they received the drugs. The licensees contend that Nevada law exempts wholesalers that have obtained authorized distributor status with the manufacturer from provid-ing pedigrees about prior sales of the drug. The Board argued that Nevada law exempts wholesalers from providing information of

nabp newsletter

182

Association News

Legal Briefs(continued from page 181)

prior sales on pedigrees only if the wholesaler is an authorized distributor and did not purchase the drug from another wholesaler. After a lengthy analysis of the statutes, the court agreed with the Board and stated:

The purpose of requir-ing a pedigree from wholesalers that meet the descriptions in either subsection (a) or (b) of NAC 639.603(1) is illustrated in a case such as this, when testi-mony before the Board revealed that [licensees] maintained authorized distributor status with TAP Pharmaceuticals so they could sell Lu-pron to other wholesal-ers without pedigrees, concealing the un-

trustworthy source of the drug. By requiring wholesalers to provide pedigrees unless they both are an authorized distributor and pur-chased the drug from an entity other than another wholesaler, NAC 639.603 serves the public policy interest in transparency in the wholesale prescription drug market.Next, the court ad-

dressed the Board determi-nations that the licensees violated applicable Nevada law by accepting and selling drugs handled and shipped by a company unlicensed in any state and by ac-cepting and selling drugs from various addresses at which no pharmaceutical wholesaler was licensed. As to a specific wholesaler, the court agreed with the licensees on this point

finding that Nevada law did not require such supplier at the time of the transactions to maintain licensure or, alternatively, such whole-saler was merely a shipping agent, rather than acting in the capacity of a wholesaler. Thus, such Board findings were reversed and resulted in the remand of the mat-ter solely to determine the extent of the fines related to such transactions.

Additional arguments by the licensees related to record keeping and alleged arbitrary and capricious action by the Board were also rejected by the court in affirming all remaining findings and sanctions.

Finally, the court ad-dressed and upheld the imposition of the costs and fines levied by the Board order, subject to the remand referenced above. The court noted that the

licensees pointed to no au-thority requiring the Board to cite the statute authoriz-ing the imposition of fines as part of its administrative order. Further, the court held that the licensees did not establish prejudice for any such failure. As empowered by the statute, the Board was authorized to fine the licensees up to $10,000 per count.

This complex and lengthy opinion addresses numerous important is-sues related to regulating entities involved in the wholesale market. Specific facts for reason of brevity have not been included in this article and readers are encouraged to further ex-amine the judicial opinion for additional details.

Dutchess Business Ser-vices, Inc v Nevada State Board of Pharmacy, 191 P. 3d 1159 (NV 2008)

NABP List of Not Recommended Internet Drug Outlets GrowsIn an effort to educate

and protect patients from illegitimate drug outlets selling medications online, NABP continues to list In-ternet drug outlets on the NABP Web site that do and do not appear to meet state and federal laws and NABP patient safety and phar-macy practice standards.

As of December 12, 2008, 1,223 sites were reported as Not Recommended. Of these sites:

1,155 sites do not require •a valid prescription780 sites offer foreign •or non-FDA-approved drugs593 sites are located out-•side the United States and selling drugs illegal-ly to patients in the US

Fifteen sites are listed as Recommended. These sites are accredited through the NABP Verified Internet Pharmacy Practice Sites™ (VIPPS®) program.

NABP recommends only those Internet pharmacies for which the Association has inspected the facilities and reviewed documentation ensuring that they meet the highest standards for phar-macy practice and patient safety. For this reason, NABP recommends that patients use VIPPS-accredited Inter-net pharmacies when buying medicine online.

The Association recognizes, however, that some non-ac-

credited Internet pharmacies may be operating legitimately. Of those entities that approve non-accredited Internet pharmacies, LegitScript.com is the only one that has agreed to adhere to NABP-recognized standards.

A full listing of Recommend-ed and Not Recommended sites, along with program crite-ria and related patient informa-tion, is available in the Internet Pharmacies section of the NABP Web site at www .nabp.net.

november-december 2008

183

. . . test results show that at least 46 million Americans are affected by drinking water contaminated with trace amounts of pharmaceuti cals.

Association News

(continued on page 184)

NABP Takes Steps to Curb Diversion, Pollution Resulting from Improperly Stored, Discarded Medications

NABP is taking steps to curb the diversion and abuse of prescription medi-cations and the contamina-tion of waterways caused by improper storage and dis-posal of medications. The Association convened a task force to address this issue and to recommend model rules for the state boards of pharmacy.

The Task Force on Medication Collection Programs met on Decem-ber 6, 2008, in Tucson, AZ, following the NABP 2008 Symposium. Its conception results from a resolution passed at the NABP 104th Annual Meeting in May 2008, which notes that:

unused, unwanted, or •expired medications may threaten public heath and safety; inappropriate disposal •of these medications may pose a significant risk to the public and threaten the environment by contaminating waterways; the increasing incidence •of drug abuse is a serious problem, and improper storage or disposal may lead to theft of medications, resulting in diversion and abuse; and medication collection •programs provide for the safe and efficient disposal of unwanted or unused medications.The task force was

charged with the following four tasks:

evaluate the status of 1. medication collection programs throughout the country; review state and federal 2. laws and regulations, including those admin-istered by the United States Drug Enforce-ment Administration, applicable to medication collection programs; suggest possible medica-3. tion collection program protocols compliant with current, applicable state and federal laws and regulations; and recommend revisions, if 4. necessary, to the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy ad-dressing this issue.The resolution and task

force furthers the objectives of a previous resolution, “Safe and Environmen-tally Friendly Medication Destruction Programs,” passed at the NABP 102nd

Annual Meeting. This reso-lution notes that improper disposal leads to increased opportunities for diversion and negatively affects the environment, and resolves that NABP and its member boards work with other stakeholders to develop programs whereby patients can safely and properly dispose of medications.

The problems are self-evident. Among the rising number of teens abusing prescription and over-the-

counter medications, the most common and imme-diate source for obtaining those medications is the medicine cabinet in their

tive; many cities found the anti-convulsant carbam-azepine, and in Colorado Springs, CO, tests revealed five pharmaceuticals in all, including a tranquilizer and a hormone, AP reports.

Solutions are more elusive. A congressional panel took place Septem-ber 18, 2008, to review the issue of pharmaceutical contaminants in the water supply. Lobbyists pushed for a new national approach that monitors the country’s waters more broadly for the presence and impact of hundreds of recently de-tected contaminants from pharmaceuticals to fire retardants, AP reports.

To prevent diversion, recommendations have in-cluded disposing of unused pills by mixing them with coffee grounds or kitty lit-ter. More complex solutions have included medication take-back programs where-in pharmacies provide locked receptacles in which patients can deposit unused medications, which are then collected and trans-ported via reverse distribu-tor to an environmentally safe disposal facility.

Recent legislation in California, for instance, allocates funds for pilot projects allowing consum-ers to drop off old prescrip-tions at retailers and public facilities and requires the California Integrated Waste Management Board to

own homes or in the homes of their friends, according to the Partnership for a Drug-Free America. Storing medications where they are not readily accessible and properly disposing of unused medications is an important step in prevent-ing diversion and abuse.

Improper disposal, how-ever, leads to environmental problems. According to the Associated Press (AP), test results show that at least 46 million Americans are affected by drinking water contaminated with trace amounts of pharmaceuti-cals. Since the release of an AP report about this prob-lem in March 2008, agen-cies in metropolitan areas have tested their drinking water, resulting in 17 posi-tive cases in cities including Reno, NV; Savannah, GA; and Huntsville, AL. Testing in Chicago, IL, for example, found a cholesterol medica-tion and a nicotine deriva-

nabp newsletter

184

associated with DMEPOS. CMS requires retail sup-pliers of DMEPOS, includ-ing pharmacies, to meet CMS-established quality standards and become accredited in order to receive reimbursement under Medicare Part B. In response to the need for pharmacies to become accredited for DMEPOS, NABP pursued and re-

ceived CMS authority to accredit pharmacies that sell DMEPOS according to CMS quality standards.

As accreditation of DMEPOS pharmacies has become a requirement for reimbursement from CMS, so, too, may accreditation of community pharma-cies become a requirement of third-party payers, the 2007 task force mem-bers surmised. Some also expressed concern that accrediting bodies whose focus is outside or much

broader than the realm of pharmacy might step in to implement a pharmacy accreditation program, overstepping the regula-tory authority of the state boards of pharmacy, if the boards themselves do not take on that task first.

Patient Safety at Heart

A community pharma-cy accreditation program developed and imple-mented by NABP would focus on systems criti-

cal to patient safety but would work in conjunc-tion with the state boards of pharmacy. Based on the Association’s success with its DMEPOS, VAWD, and VIPPS programs, NABP is prepared to move forward on such a project, with the guidance of the boards of pharmacy and other stakeholders, to assist the boards in their efforts to uphold pharmacy CQI and practice standards and, ultimately, to im-prove patient care.

Association News

establish a model pharma-ceutical take-back program for the state. Other states have attempted medica-tion recycling programs, wherein certain unused medications are collected and redistributed to long-term care or other facilities. (See “States Implement Dis-posal, Recycling Programs to Reduce Diversion and Pollution Resulting from

Unused Medications” in the October 2007 issue of the NABP Newsletter.)

The recommendations of the task force will be posted on the NABP Web site after they have been approved by the NABP Executive Committee in spring 2009.

The task force comprises the following members: Edith Goodmaster, Con-necticut Commission of Pharmacy; James Kamin-ski, RPh, Delaware State Board of Pharmacy; John

NABP Takes Steps to Curb Diversion(continued from page 183)

Kirtley, PharmD, Arkansas State Board of Pharmacy; Heather Pasquale, RPh, Ohio State Board of Pharmacy; Sandra “Sandy” Robin RPh, Delaware State Board of Pharmacy; Kenneth Schell, PharmD, California State Board of Pharmacy; Frank Whitchurch, RPh, Kansas State Board of Pharmacy; and Betty Yamashita, RPh, Utah Board of Pharmacy. John R. Dorvee, Jr, PharmD, of Maine, served as chair-man of the task force, and Elizabeth Scott “Scotti” Rus-

sell, RPh, served as the Ex-ecutive Committee liaison. The ex officio members were Connie T. Jung, RPh, PhD, Food and Drug Administra-tion/Office of the Commis-sioner, and Michael Grafton, diversion group supervisor, Drug Enforcement Admin-istration. Invited guests included Janet Goodwin, US Environmental Protection Agency; Harry Hagel, MS, RPh, American Pharmacists Association; and Shirley Re-itz, PharmD, Group Health Cooperative.

Pharmacy Accreditation(continued from page 178)

Updated 2009 Survey of Pharmacy Law Now AvailableThe NABP 2009

Survey of Pharmacy Law, providing a concise research source for key regulatory questions in pharmacy practice, is now available.

The Survey consists of four sections includ-ing a state-by-state overview of organiza-tional law, licensing law,

drug law, and census data. Also included, is a new question in Section VII, “Issuance of Initial Phar-macist Licensure,” which asks whether or not states require criminal history record checks for initial licensure as a pharmacist. Updates for the Survey were graciously provided by the state boards of pharmacy.

The Survey can be pur-chased for $20 by visiting the publications section of the NABP Web site at www .nabp.net, download-ing the publications order form, and mailing it to NABP Headquarters with a check or money order made payable to NABP.

A l l f ina l-year phar-macy students receive

the CD-ROM free of charge through the generous sponsorship of Purdue Pharma LP.

More information on the Survey is avail-able by contacting customer service via phone at 847/391-4406 or via e-mail at custserv@nabp .net.

november-december 2008

185

Association News

NABP Task Force Examines Standardization of Medication Container Labels to Aid in Prevention of Errors

In recent years, concerns have arisen regarding pre-scription drug label format and content as it relates to medication errors. An estimated 1.5 million medi-cation errors occur each year, according to a report released by the Institute of Medicine in 2006, and poor label readability is a contributor to this disturb-ing number.

Recognizing the serious-ness of this issue, at its 104th Annual Meeting in May 2008, the NABP member-ship adopted a resolution to convene a task force to explore uniform prescrip-tion labeling requirements. Held on December 6, 2008, at the JW Marriott Starr Pass Hotel in Tucson, AZ, the task force was charged with

Evaluating current state 1. and federal laws and regulations addressing prescription label format and contentReviewing the results 2. of the findings of the state and federal studies regarding prescription labeling Studying the feasibility 3. of implementing stan-dardized state require-ments for prescription label format and content and for patient medica-tion informationRecommending revi-4. sions, if necessary, to the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) address-

proprietary or generic name of the drug and its strength, name of the manufacturer or distributor, beyond-use date, and – if dispensed

ing these issues so as to increase readability and comprehension of labels by patientsThe convening of this

task force is an important step in putting the state boards of pharmacy in a position to retain control over label standardization, as some organizations call for a national standardization of prescription labels. Because establishing regulatory con-sistency from state to state is in the best interest of the public health, NABP is work-ing with and on behalf of the boards of pharmacy and with national organizations to develop model language for use by the boards in crafting their own regula-tions. Any model rules cre-ated will be included in the Model Act for all state boards to reference.

Currently, the Model Act includes recommended language for basic prescrip-tion drug container label requirements in Section 3 E (4) of the Model Rules for the Practice of Phar-macy. The Model Act states that labels shall include the following information: name and address of the dispensing pharmacy, name of the patient, name of the prescribing practitioner, directions for use as stated on the prescription drug or-der, date of dispensing, any cautions required by federal or state law, serial number of the prescription drug or-der, name or initials of the dispensing pharmacist, the

pharmacies, which claim they must have 31 different label formats for use in the 50 states.

Current labeling prac-tices leave room for patient confusion as well. A study published in 2006 in the Annals of Internal Medicine shows that 46% of patients taking part in a medical literacy study misunderstood one or more instructions printed on the container labels of five common pre-scription medications. The study, “Literacy and Mis-understanding Prescription Drug Labels,” found a higher frequency of misunder-standing label instructions in patients with low literacy, in elderly patients, and in patients taking multiple pre-scription medications.

Adding to patients’ confusion is the variabil-ity between prescription drug labels, as well as label formatting that emphasizes the prescribers’ instructions to the pharmacy, as opposed to patient instructions on proper use of the medica-tion. The American College of Physicians Foundation (ACPF) notes that the dose and frequency schedule for the same prescribed medi-cation may be written in several different ways, with varying degrees of specific-ity, eg, twice daily, every 12 hours, once in the morning and once in the evening, or at 8 am and 5 pm. Some labels also include Latin or other abbreviations,

(continued on page 186)

The convening of this task force is an important step in putting the state boards of pharmacy in a position to retain control over label standardization, as some organizations call for a national standardization of prescription labels.

via a centralized prescrip-tion processing or filling system – a code that pro-vides an audit trail of the dispensing and pharmacist care activities.

The Federal Food, Drug, and Cosmetic Act requires container labels to include the name and address of the dispensing pharmacy, serial number and date of the prescrip-tion or of its filling, name of the prescriber, name of the patient (if stated in the prescription), instructions for use, and any cautionary statements. State boards of pharmacy have the author-ity to implement additional requirements. Inconsisten-cies between states’ require-ments, however, complicate matters, especially for chain

nabp newsletter

186

Association News

Deadline Set for Proposed Amendments to NABP Constitution and Bylaws

NABP Seeks Board Input on Resources and Responsibilities

Every two years, NABP collects and publishes informa-tion regarding board of pharmacy resources and responsibilities. Over the years, this informa-tion has proven to be a valuable resource to the boards during legislative hearings, budget prepa-ration, strategic plan-ning, human resources planning, and office management.

The survey will be distributed to boards of pharmacy electroni-cally in January 2009. The participation of every state board is essential to the success of the survey. NABP looks forward to receiving each board’s completed survey and will distribute the compiled findings to the boards in April 2009.

Proposed amendments to the NABP Constitution and Bylaws must be sub-mitted between Monday, February 16, 2009, and Thursday, April 2, 2009, for consideration during the 105th Annual Meeting, which will be held May 16-19, 2009, at the Hyatt Regency Miami in Florida.

Amendments must be submitted in writing to NABP Executive Direc-tor/Secretary Carmen A. Catizone at NABP Head-quarters, 1600 Feehanville

Sponsorship and Educational Grant Opportunities Available to Organizations for NABP 105th Annual Meeting

Organizations have an op-portunity to gain exposure through numerous sponsorship and educational grant opportuni-ties available at the NABP 105th Annual Meeting to be held May 16-19, 2009, at the Hyatt Regency Miami in Florida. Organizations that contribute help NABP pro-vide quality programs designed to assist board members, executive

officers, and compliance staff to meet their responsibilities for safe-guarding the public health while creating visibility for the sponsor-ing organization. All contributing organizations will be recognized by session or event, and will also be identified in meeting program materials, the NABP Newsletter, on meeting signage, and on the NABP Web site at www.nabp.net.

In addition, sponsoring organiza-tions contributing $5,000 or more to the meeting are entitled to two complimentary meeting registra-tions valued at $575 each. Contri-butions of $1,000 to $4,999 entitle the donors to one complimentary meeting registration. For more details on sponsorship and grant opportunities, organizations may e-mail custserv@nabp .net.

and most are formatted to emphasize the dispensing pharmacy’s logo and name, ACPF reports.

The recommendations of the task force will be posted on the NABP Web

site after the task force report has been approved by the NABP Executive Commit-tee in spring 2009. For more information on prescription labeling, see “Standardized Medication Container Labels Touted as Prescription for Patient Safety” in the March 2008 NABP Newsletter.

The task force comprises the following members: Barry Boudreaux, RPh,

Nevada State Board of Pharmacy; Karen DiStefano, RPh, Rhode Island Board of Pharmacy; Patricia Donato, RPh, New York State Board of Pharmacy; Virginia Herold, MS, California State Board of Pharmacy; Ronald Huether, RPh, South Dakota State Board of Pharmacy; William Prather, RPh, Georgia State Board of Pharmacy; and Leo Ross, RPh, Virginia Board of

Medication Container Labels for Error Prevention(continued from page 185)

Pharmacy. Michael Romano, RPh, of the Pennsylvania State Board of Pharmacy chaired the task force and Karen M. Ryle, MS, RPh, of Massachusetts was the Execu-tive Committee liaison. In-vited guests included Colleen Brennan, RPh, United States Pharmacopeia, and Darren K. Townzen, RPh, MBA, Na-tional Council for Prescrip-tion Drug Programs

Dr, Mount Prospect, IL 60056. Submission dates are established by the NABP Constitution and Bylaws, which specifies that pro-posed amendments may be accepted no earlier than 90 days and no later than 45 days before the first busi-ness session of the Annual Meeting.

For more information on the proposed amendments to the NABP Constitution and Bylaws, please contact the NABP Executive Office at exec-office@nabp.net.

november-december 2008

187

105th Annual Meeting

NABP Travel Grant Offered to Defray Annual Meeting Costs NABP is again offering

a travel grant for the 105th Annual Meeting to be held May 16-19, 2009, at the Hyatt Regency Miami in Florida. The Association es-tablished the grant to assist boards in sending represen-tatives to the Annual Meet-ing so they may participate in important business including discussing and voting upon resolutions, electing NABP Executive

Committee members and officers, and attending educational sessions regard-ing current issues facing pharmacy regulators.

The NABP Annual Meeting travel grant pro-gram was created to lessen costs for designated state board of pharmacy vot-ing delegates by providing funds for travel expenses, including airfare, hotel rooms, meals, taxis, park-

ing, and tips. Qualified voting delegates will have the opportunity to receive up to $1,200 in grant mon-ies to attend the NABP 105th

Annual Meeting. The grant does not include Annual Meeting registration fees.

Last year, NABP was able to provide 30 state boards of pharmacy with grants to at-tend the NABP 104th Annual Meeting. Grant applications and submission instruc-

tions may be obtained from NABP upon the direct requests of executive of-ficers of the state boards of pharmacy. NABP requests that applications be submit-ted by executive officers to NABP Headquarters prior to the Annual Meeting. Questions may be directed to exec-office@nabp.net. All applicants will be informed of whether or not they have qualified for the grant.

Call for Posters: Session Participants to Network, Share InformationState boards of phar-

macy members and staff and schools and colleges of pharmacy are invited to par-ticipate in the Educational Poster Session, “Continuous Quality Improvement,” dur-ing the NABP 105th Annual Meeting. The Annual Meet-ing will be held May 16-19, 2009, in Miami, FL, and is themed “NABP Miami: Quality Care – It’s Hot! Hot! Hot!”

The Poster Session is a one day event scheduled for Sunday, May 17, from 8-11:30 am, and will offer those displaying posters the opportunity to share information about their organization’s latest legisla-tive issues, technology, policy development, and/or disciplinary cases as they relate to continuous quality improvement, with other pharmacy professionals.

Provided for the first time at the 104th Annual Meeting as a new oppor-tunity to earn continu-

ing pharmacy education (CPE), the poster session was heavily attended in 2008. Participants may earn one contact hour (0.1 CEU) of Accredita-tion Council for Pharmacy Education-approved CPE credit for their attendance and participation. It should be noted, however, pre-senters are not automati-cally qualified for CPE. To earn CPE, presenters and participants must spend at least 50 minutes inter-acting with other Poster Session presenters.

Participating boards and schools and colleges of pharmacy will be pro-vided with one four-foot by six-foot bulletin board, which should be manned by a qualified representa-tive during display times. Posters must coincide with the Poster Session theme, “Continuous Quality Improvement.” Assem-bly time will be available on Sunday, May 17, from

6:30-7:45 am. Student pre-senters are welcome and must be accompanied by a licensed pharmacist. Par-ticipating pharmacy school students will receive a free voucher valued at $50 to take the Pre-NAPLEX®, a practice examination for students preparing for the

North American Pharma-cist Licensure Examina-tion®.

Those interested in par-ticipating should contact NABP Professional Affairs Manager Eileen Lewalski via e-mail at elewalski@nabp .net by Monday, March 2, 2009.

Tips for Submitting a Poster

For those interested in participating in the Poster Session, the fol-lowing is a list of tips on preparing a poster:

Poster topics must •adhere to the theme “Continuous Quality Improvement.”

Make the font size large •enough and double-space paragraph lines to ensure readability from two to four feet.

Enlist the help of stu-•dents and/or interns on

rotation in your office to prepare the poster.

Prepare handouts to •provide an overview of the poster and/or additional information including contact names, should attendees have questions.

The display should be •manned by a qualified representative throughout the duration of the session.

nabp newsletter

188

Association News

Community Pharmacy Accreditation Standards ReviewedThe Task Force to Review Accreditation Standards for Community Pharmacy met on October 28-29, 2008. Pictured above from left to right: Paul Limberis, RPh, member, Colorado State Board of Pharmacy; ex officio member Kent Summers, PhD, representative for Pharmacy Quality Alliance; Robert Marshall, PharmD, member, Nebraska Board of Pharmacy; ex officio member Arlene Flynn, RPh, PhD, vice president, professional affairs, American Association of Colleges of Pharmacy; ex officio member Ron Fitzwater, executive committee member, National Alliance of State Pharmacy Associations; Michael A. Podgurski, RPh, member, Pennsylvania State Board of Pharmacy; ex officio member Janet Teeters, RPh, MS, director of accreditation services, American Society of Health-System Pharmacists; Kim A. Caldwell, RPh, member, Texas State Board of Pharmacy; Sara St. Angelo, PharmD, member, Indiana Board of Pharmacy; ex officio member Phil Burgess, national director, pharmacy affairs, Walgreen Co; ex officio member Anne Burns, RPh, vice president, professional affairs, American Pharmacists Association; ex officio member Diane Darvey, PharmD, JD, director of regulatory affairs, National Association of Chain Drug Stores; Oren M. Peacock, Jr, RPh, NABP Executive Committee liaison; James DeVita, RPh, member, Massachusetts Board of Registration in Pharmacy; ex officio member Peter Vlasses, PharmD, BCPS, FCCP, executive director, Accreditation Council for Pharmacy Education; and William “Bill” Fitzpatrick, RPh, former member, Missouri Board of Pharmacy.

Newly Accredited DMEPOS FacilitiesThe following facilities were recently accredited through the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) program:

Becker Professional PharmacyChicago, IL Accredited September 16, 2008

Calmont PharmacyStockton, CA Accredited September 17, 2008

Yee’s Prescription PharmacyLong Beach, CAAccredited September 30, 2008

A full listing of accredited DMEPOS facilities is available on the NABP Web site at www.nabp.net.

Task Force Members Convene to Review TOEFL iBT RequirementsThe Task Force to Review TOEFL iBT Score Requirements convened on October 28-29, 2008. Recommendations will be posted on the NABP Web site after they have been approved by the NABP Executive Committee in spring 2009. Pictured from left to right: Kevin Mitchell, RPh, former member, Ohio State Board of Pharmacy; Anne Policastri, PharmD, MBA, member, Kentucky Board of Pharmacy; Task Force Chair Lawrence H. “Larry” Mokhiber, MS, RPh, executive secretary, New York State Board of Pharmacy; NABP Executive Committee Liaison Cathryn J. Lew, RPh; W. Benjamin Fry, RPh, FIACP, FACA, member, Texas State Board of Pharmacy; Jeanne Waggener, RPh, member, Texas State Board of Pharmacy; Thomas Bender, RPh, member, New Jersey Board of Pharmacy; and Kevin Borcher, RP, member, Nebraska Board of Pharmacy.

november-december 2008

189

Feature News

California Legislature Extends Deadline for Implementing Track-and-Trace Technology

Recent legislation in California extends the deadline for full implemen-tation of track-and-trace technology until 2017, replacing the California State Board of Pharmacy’s previous 2011 deadline. De-spite the delay, “we believe we have the right process to provide the protection the public needs,” said Virginia “Giny” Herold, MS, execu-tive officer of the Board, adding, “we’re glad the sup-ply chain is on board.”

In 2004, the California legislature adopted Board of Pharmacy-sponsored legislation, which required that members of the distri-bution system establish a pedigree system that tracks and traces prescription drugs from the point of manufacture to the point of dispensing. In 2006, the Board sponsored legislation that set the implementation date for the pedigree system as January 1, 2009. That legislation also gave the Board the authority to delay implementation until 2011 if industry showed good cause for the delay. Early in 2008, after having heard concerns from industry rel-ative to the 2009 deadline, the California State Board of Pharmacy took action to delay the implementation of the pedigree system until January 1, 2011.

On August 26, 2008, the California Legisla-ture passed a new piece of legislation that replaced the Board’s 2011 deadline

and further extends the deadline for implementing the electronic track-and-trace pedigree system. The legislation ultimately delays full implementation of the end-to-end pedigree system until July 1, 2017.

On September 30, 2008, Governor Arnold Schwarzenegger signed the bill into law.

The original intent of the law is to address threats to the prescription drug supply from counterfeit, misbranded, adulterated, or diverted drugs, accord-ing to a statement from the California Board. “The overall intent is to secure the drug distribution sys-tem and to enable through heightened security a sus-tained and increased con-fidence in the authenticity and efficacy of prescription drugs,” the Board states.

The legislation prohibits a wholesaler, repackager, or pharmacy from selling, trading, or transferring a prescription drug without a pedigree or from acquiring a prescription drug with-out receiving a pedigree. The pedigree must contain certain information includ-ing the source of the drug, the trade or generic name of the drug, and, effective January 1, 2015, a speci-fied unique identification number.

The new law creates a graduated implementa-tion schedule requiring manufacturers to serialize half of their product lines

by January 1, 2015, for tracking throughout the supply chain and requir-ing the remaining 50% to be completed the follow-ing year. Pharmaceutical wholesalers have until July 1, 2016, to meet the ePedi-gree requirements, and pharmacies must comply no later than July 1, 2017. These dates were agreed upon by the supply chain members to allow suf-ficient time to prepare for implementation.

The Board supported the graduated implementa-tion, as it not only gives the manufacturers the oppor-tunity to prioritize their highest-risk drug products, but also allows the manu-facturers, wholesalers, and pharmacies to pilot test the ePedigree system and “work the bugs out without inter-rupting the drug supply to patients,” Herold said.

The law does not dictate a particular technology for serialized pedigree but allows the manufacturer to determine the most suit-able technology solution. It does include provisions for the grandfathering of existing drug supplies into the supply chain and requires the Board to develop regulations for verifying and validating the receipt of pharmaceuti-cal shipments.

More information about the new law is avail-able on the Board Web site at www .pharmacy.ca.gov/about/e_pedigree.shtml.

Around the AssociationExecutive Director Changes

Anita O. Martin, MPA, has been appointed executive director of the Georgia State Board of Pharmacy. Martin began her appointment on September 18, 2008. Prior to this position, she served as the executive director for the Georgia State Board of Dispens-ing Opticians, Georgia State Board of Hearing Aid Dealers and Dispens-ers, Georgia State Board of Optometry, and the Georgia Board of Podi-atric Examiners. Martin obtained her bachelor of arts degree in sociology and master of public ad-ministration degree from Valdosta State University.

Louisiana Board Members Honored

Three Louisiana Board of Pharmacy members were honored during the Louisiana Pharmacists Association 126th Annual Meeting, held in August 2008. Richard “Andy” Soileau, RPh, received the Meritorious Achieve-ment Award from the University of Louisiana at Monroe College of Pharmacy, Marty McKay, RPh, received the Innova-tive Pharmacy Practice Award, and Allen W. Cassidy, Jr, RPh, received the Bowl of Hygeia Award. All three recipients are also past presidents of the

(continued on page 193)

nabp newsletter

190

Professional Affairs Update

Appellate Court Ruling Upholds Injunction of FDA Pedigree Rule

The US Court of Ap-peals for the Second Circuit in New York has upheld an injunction of the Food and Drug Administra-tion (FDA) rule regarding pedigree requirements for wholesalers. FDA issued the requirements, which went into effect on Decem-ber 1, 2006, to implement provisions of the Prescrip-tion Drug Marketing Act of 1987, as amended by the Prescription Drug Amendments of 1992. The injunction prohibits FDA from implementing the language in the regulation that (1) requires a pedigree to identify each prior sale, purchase, or trade of a drug back to the drug’s original manufacturer, and (2) that specifies the different types of information, including lot numbers and container sizes, that must be included in a pedigree. The injunc-tion does not affect other parts of the regulation.

FDA has indicated that, as long as the court’s order is in effect, it does not intend to initiate any en-forcement actions against any wholesalers solely for failing to include lot num-bers, dosage, container size, or number of containers on a pedigree; or for failing to provide a pedigree that goes back to the manu-facturer so long as the pedigree otherwise iden-tifies the last authorized distributor of record that handled the drugs. More information is available on the FDA Web site at www .fda.gov/cder/regulatory/PDMA/default.htm.

FDA Embarks on Major Hiring Initiative to Strengthen Its Public Health Mission

Biologists, chemists, medical officers, math-ematical statisticians, and investigators are among the experts in demand as FDA begins a multi-year hiring initiative. FDA is hiring hundreds of individuals with science and medical

backgrounds to help meet the agency’s responsibilities to ensure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics, and prod-ucts that emit radiation. In fiscal year 2008 alone, FDA is looking to fill more than 600 new positions and to backfill more than 700 others to implement the FDA Amendments Act of 2007, the Food Protection Plan, and the Import Safety Action Plan. That is nearly triple the number of people hired from 2005 to 2007. More information is avail-able on the FDA Web site.

California Awareness Project Aims to Divert Pharmaceuticals from Water Supply

State and local officials in California joined forces with the US Environmental Protection Agency for a “No Drugs Down the Drain Week” October 4-11, 2008. The statewide campaign recommends that unused medications be dropped

NEWLY ACCREDITED VAWD FACILITIES

The following facilities were recently accredited through the NABP Verified-Accredited Wholesale Distributors® (VAWD®) program:

A full listing of accredited VAWD facilities is available on the NABP Web site at www.nabp.net.

Butler Animal Health Supply, LLCTualatin, ORFort Worth, TXAccredited August 15, 2008

Cardinal Health 100, Inc dba Cardinal HealthKansas City, MOAccredited August 21, 2008

Cardinal Health 200, dba Cardinal HealthMontgomery, NYAccredited August 15, 2008

EXP Pharmaceutical Services CorporationFremont, CAAccredited September 22, 2008

Howell Marketing Services, a division of F.M. Howell and CompanyElmira, NYAccredited August 25, 2008

MWI Veterinary Supply CoFife, WAVisalia, CAAccredited August 15, 2008

Novis Pharmaceuticals, LLCMiami, FLAccredited September 4, 2008

UPI Texas, Inc dba Unique Pharmaceuticals Temple, TXAccredited September 22, 2008

off at special collection sites or mixed with water, sealed, and tossed in the trash. The awareness week is a spin-off of Senate Bill (SB) 966, signed into law in 2007, which allocates funds for pilot projects allow-ing consumers to drop off old prescriptions at retail-ers and public facilities. The legislation requires the California Integrated Waste Management Board (CIWMB) to establish a model pharmaceutical take-back program for the state. The “No Drugs Down the Drain!” campaign is coordinating with the CIWMB so that data and lessons learned from the campaign can assist in the implementation of SB 966. More information about the campaign and alterna-tive disposal methods is available at www.nodrugs downthedrain .org.

In December 2008, NABP convened the Task Force on Medication Col-lection Programs to further address this issue. More details on this task force are located on page 183.

november-december 2008

191

State Board News

VA Board Passes New Requirements for Nonresident Pharmacies

The Virginia General Assembly passed a law, effective July 1, 2008, that contains two new provi-sions that affect non-resident pharmacies. The first requirement man-dates that nonresident pharmacies, other than those providing services as pharmacy benefits ad-ministrators, designate to the Board the name and license number of a Vir-ginia licensed pharma-cist-in-charge (PIC) who will be responsible for the nonresident pharmacy’s compliance with Virginia laws. This information must be reported at the time of the next renewal (anticipated to be April 30, 2009) and annually thereafter, or within 30 days of any change in PIC. Pharmacists licensed in other states, in most cases, may obtain a Vir-ginia license by using the NABP licensure transfer process and passing the Virginia Federal and State Drug Law Exam.

The second statu-tory change requires a nonresident pharmacy to be accredited by NABP through the Verified In-ternet Pharmacy Practice Sites™ (VIPPS®) program, or certified by a substan-tially similar program approved by the Board, if the pharmacy dispenses more than 50% of its total prescription volume pursuant to prescriptions

received as a result of so-licitation on the Internet to include solicitation by e-mail.

More information on the NABP licensure trans-fer process and the VIPPS accreditation program is available on the NABP Web site at www.nabp.net.

Iowa Board Publishes New Pharmacy Technician Rules

The Iowa Board of Pharmacy recently adopted a new chapter of rules for pharmacy technicians.

Pursuant to this new chapter, all pharmacy technicians are required to be certified by July 1, 2010. The Board is cur-rently working with the Iowa Pharmacy Asso-ciation and other inter-ested parties to identify pharmacy-supportive personnel who may assist pharmacists by perform-ing non-technician func-tions. Both the Pharmacy Technician Certification Board (PTCB) and the Institute for the Cer-tification of Pharmacy Technicians are now accredited by the Com-mission for Certifying Agencies and, therefore, are recognized by the Board as national certifi-cation bodies in Iowa.

The new rule is avail-able in its entirety in the August 2008 Iowa Board of Pharmacy Newsletter available in the Newslet-ters section of the NABP Web site at www .nabp .net.

Prescription Drug Monitoring Program Now Live in Colorado

The Colorado State Board of Pharmacy an-nounced in its August 2008 Newsletter that its elec-tronic prescription drug monitoring program is now “live.” Pharmacists and prescribers of controlled substances may now regis-ter and access data in order to provide the most appro-priate treatment for their patients. Additional infor-mation about the program is available on the Board’s Web site, www .dora.state .co.us/pharmacy, or at www .coloradopdmp .org.

State Certification Process Approved for SC Technicians

Proviso 65.9 allows for a one-time state certification process for South Carolina pharmacy technicians who did not obtain state certi-fication by the deadline of June 30, 2004. During fiscal year 2008-2009, funds were appropriated to the Depart-ment of Labor, Licensing, and Regulation Division of Professional and Occupa-tional Licensing, to imple-ment a one-time certifica-tion process for pharmacy technicians who have met the academic and supervised practice requirements as of June 30, 2004, but failed to submit all of the required information in accordance with the Board’s submission requirements. These indi-viduals must have met all the requirements of Section 40-43-82 (A), (B), (C). (continued on page 192)

The Board is offering this one-time opportu-nity to be certified based upon the credentials the individual had in place on July 1, 2004. Individuals must also show current PTCB certification, and be current with continuing education requirements. Applications must be submitted to the Board office by midnight June 30, 2009.

More information can be found on the South Carolina Board of Phar-macy Web site at www.llr.state .sc.us/pol/pharmacy.

New Legislation Requires Pharmacy Technician Registration in Kentucky

House Bill 328 (KRS 315.135, KRS 315.136, KRS 315.137, and KRS 315.138), sponsored by Representa-tive Susan Westrom, was passed during Kentucky’s 2008 legislative session and signed by Kentucky Governor Steve Beshear. It requires the registration of all pharmacy technicians with a $25 fee by April 1, 2009. The Kentucky Board of Pharmacy is currently working on the application process and will provide additional information to pharmacies and phar-macists via e-mail, the Board’s Web site, and pro-fessional organizations as the process develops. The laws are available on the Board’s Web site at www .pharmacy .ky.gov. Ques-tions may be directed to the Board office.

nabp newsletter

192

State Board News

State Board News(continued from page 191)

MN Disciplines Pharmacists for Dispensing Illegal Internet Prescriptions

The Minnesota Board of Pharmacy recently disciplined five pharma-cists and one pharmacy for involvement with Internet Web sites that offered to arrange for the sale of legend drugs. The Web sites paid physicians and a physician assistant, licensed in other states, to write prescriptions based on their review of ques-

tionnaires filled out by customers. In one case, the prescribers supposedly also reviewed copies of medical records submitted by the customers.

Those purported pre-scriptions were then made available electronically to the pharmacists who worked at two licensed Minnesota pharma-cies, Byron Marketplace Pharmacy in Byron, MN, and Market Pharmacy in Bemidji, MN. The pharmacists shipped legend drugs to customers located across the coun-try. Controlled substances were shipped by the Be-

midji, but not the Byron, pharmacy. The actions of the pharmacists violated a number of state and federal laws and rules.

The Minnesota Board has the authority to pur-sue action against phar-macists and pharmacies involved in the process-ing of prescriptions that they know originate from illegitimate Web sites.

The Minnesota legis-lature passed a law ear-lier this year that estab-lishes that prescriptions for controlled substances and certain other drugs (carisoprodol, trama-dol, muscle relaxants,

Task Force Convenes to Discuss Pharmacy Technician Education and Training StandardizationOn September 9-10, 2008, the Task Force on Standardized Pharmacy Technician Education and Training met to assess the feasibility, in regard to the protection of the public health, of the states implementing standardized state requirements for technician education andor training. Pictured above from left to right: Gay Dodson, RPh, executive director/secretary, Texas State Board of Pharmacy; guest Jan Keresztes, PharmD, RPh, coordinator, Pharmacy Technician Program, South Suburban College; Gregory Braylock, Sr, RPh, NABP Executive Committee liaison; Jeane Johnson, RPh, former inspector, New Mexico Board of Pharmacy; Task Force Chair Susan Ksiazek, RPh, member, New York State Board of Pharmacy; Wendy Anderson, RPh, program director, Colorado State Board of Pharmacy; Lee Ann Bundrick, RPh, administrator, South Carolina Department of Labor, Licensing, and Regulation – Board of Pharmacy; Jacqueline Hall, RPh, member, Louisiana Board of Pharmacy; guest Melissa Murer Corrigan, RPh, executive director and chief executive officer, Pharmacy Technician Certification Board; guest Douglas Sheckelhoff, MS, FASHP, American Society of Health-System Pharmacists; and guest Kevin Nicholson, RPh, JD, vice president of pharmacy regulatory affairs, National Association of Chain Drug Stores.

and erectile dysfunc-tion drugs) are not valid unless the prescriptions or orders are based on a documented patient evaluation, including an in-person examination, adequate to establish a diagnosis and identify underlying conditions and contraindications to treatment. Pharma-cists are prohibited from knowingly dispensing such prescriptions. This provision is intended to prevent pharmacies and pharmacists from con-tracting or knowingly working with illegiti-mate Web sites.

november-december 2008

193

Feature News

Rx Response Supports Continued Delivery of Needed Medicines in Emergencies

Along with high wind and heavy rain, Hurricanes Gustav and Ike brought with them stark remind-ers of the need to prepare for an emergency situa-tion so that patient access to prescription medica-tions remains unimpeded. To support public health related responses, mem-bers of the pharmaceutical supply system sponsored the development of Rx Response, which provides an information sharing and problem solving forum for the private pharmaceuti-cal supply system, disaster relief agencies, and govern-ment to help ensure the continued delivery of criti-cal medicines to patients whose health is threatened by a severe public health emergency.

Rx Response was devel-oped nearly two years ago in response to Hurricane Katrina and the threat of pandemic influenza. Its primary focus is to en-sure that the pathways of communication remain as clear as possible in times of a severe public health emergency to help sup-port the continued delivery of needed medicines. In summer and fall 2008, the system has been activated in response to Hurricane Ike, Tropical Storm Hanna, and Hurricane Gustav, and has monitored the wildfire emergency in California.

Rx Response is a single point of contact for the entire pharmaceutical sup-

ply system and relies on a network that allows federal and state emergency man-agement officials to com-municate with Rx Response

Health Organization Phase IV+ Event, or a Health and Human Services Stage 2+ Event. The position of Rx Response is that normal business practices are able to handle most local situ-ations, but during severe public health emergen-cies, Rx Response will help facilitate communication between various points in the pharmaceutical sup-ply chain to help ensure that patients receive their medications.

Partners in Rx Response include the American Hos-pital Association, American Red Cross, Biotechnology Industry Organization, Generic Pharmaceutical Association, Healthcare Dis-tribution Management As-sociation, National Associa-tion of Chain Drug Stores, National Community Phar-macists Association, Phar-maceutical Research and Manufacturers of America, and various government agencies. Rx Response seeks to partner with other agen-cies and industries involved in this process to help minimize barriers hinder-ing the supply of medicines during severe public health emergencies.

More information is available on the Rx Response Web site at www.rxresponse.org. More information about current emergency declarations and disaster situations is avail-able from the US Depart-ment of Homeland Security at www.DisasterHelp.gov.

Around the Association(continued from page 189)

association. In addition to these awards, the Board of Pharmacy presented War-ren Guidry, RPh, with a gold certificate com-memorating his 50 years of pharmacy practice.

Survey Luncheon Winner

Congratulations to the Kansas State Board of Pharmacy for win-ning the 2009 Survey of Pharmacy Law Luncheon Drawing. NABP awarded the Board $125 towards a Board member and staff luncheon for returning their updated Survey data by the July 25, 2008 deadline.

NABP Donates Bikes to Maryville Academy

NABP staff gathered for a team building exercise on Friday, August 1, 2008, to assemble bicycles, which the Association donated to the children of Maryville Academy in Des Plaines, IL. For 125 years, Maryville Academy has helped build a better community in Chicago by improving the lives of children and fami-lies in need.

Board Member Appointments

Ronald Wallace • has been appointed a public member of the Georgia State Board of Phar-macy. Wallace’s ap-pointment will expire on July 6, 2013.

(continued on page 194)

Rx Response is a single point of contact for the entire pharmaceutical supply system . . .

regarding pharmaceutical needs and other issues that may impact the supply sys-tem. The communications are actively monitored by all segments of the pharma-ceutical supply system to ensure the fastest possible resolution.

The planning and response activities of Rx Response focus on severe US public health emergen-cies arising from a natu-ral disaster, pandemic or act of bioterrorism, and include international public health considerations that may affect the delivery of critical medicines in the US. Its effort is focused on addressing incidents of national significance. A public health emergency is determined on a case-by-case basis by employing the following guidance: disas-ter declaration by a US state governor or the US presi-dent, American Red Cross Level V+ Event, Depart-ment of Homeland Security Severe Classification, World

nabp newsletter

194

Association News

Lora Williams, JD, • has been appointed a public member of the Indiana Board of Pharmacy. Wil-liams’ appointment will expire on July 1, 2010.

Annabelle Diehl • has been appointed a pub-lic member of the Iowa Board of Pharmacy. Diehl’s appointment will expire on April 30, 2011.

Edward Maier, RPh, • has been appointed a mem-ber of the Iowa Board of Pharmacy. Maier’s ap-pointment will expire on April 30, 2011.

Sydnie Durand • has been appointed a public member of the Louisiana Board of Pharmacy, and is serving at the discre-tion of the appointing body.

Ronald Moore, RPh, •has been appointed a member of the Louisi-ana Board of Pharmacy. Moore’s appointment will expire on July 28, 2014.

Richard “Andy” Soi-•leau, RPh, has been appointed a member of the Louisiana Board of Pharmacy. Soileau’s ap-pointment will expire on July 28, 2014.

Richard Matens • has been appointed a public member of the Mary-land Board of Pharmacy. Matens’ appointment will expire on July 1, 2012.

Edward Rivet • has been appointed a public member of the Michigan Board of Pharmacy. Rivet’s appointment will expire on June 30, 2011.

Larry Cartier, RPh, • has been appointed a member of the Oregon State Board of Pharmacy. Cartier’s appointment will expire on June 30, 2012.

Charles Stephens, RPh, •has been appointed a member of the Tennessee Board of Pharmacy. Ste-phens’ appointment will expire on July 31, 2014.

Board Member Reappointments

Kathleen “Kitty” W. •Gurnsey has been reap-pointed a public member of the Idaho State Board of Pharmacy. Gurnsey’s appointment will expire on June 30, 2013.

Patrick Adams, RPh, •has been reappointed a member of the Hawaii State Board of Pharmacy. Adams’ appointment will expire on June 30, 2012.

Donna S. Wall, •PharmD, RPh, has been reappointed a member of the Indiana Board of Pharmacy. Wall’s appointment will expire on June 30, 2012.

Carl Aron, RPh, • has been reappointed a member of the Louisiana Board of Pharmacy. Aron’s appointment will expire on July 28, 2014.

Jacqueline Hall, RPh, •has been reappointed a member of the Louisi-ana Board of Pharmacy.

Hall’s appointment will expire on July 28, 2014.

Marty McKay, RPh, •has been reappointed a member of the Louisiana Board of Pharmacy. Mc-Kay’s appointment will expire on July 28, 2014.

Mayer Handelman, RPh, •has been reappointed a member of the Maryland Board of Pharmacy. Handelman’s appointment will expire on April 30, 2012.

Sara Fakhoury, RPh,• has been reappointed a member of the Michigan Board of Pharmacy. Fak-houry’s appointment will expire on June 30, 2012.

Ann Zweber, RPh, • has been reappointed a mem-ber of the Oregon State Board of Pharamcy. Zwe-ber’s appointment will expire on June 30, 2012.

Gill Abernathy, RPh, • has been reappointed a mem-ber of the Virginia Board of Pharmacy. Abernathy’s appointment will expire on June 30, 2012.

Brandon K. Yi, RPh, •has been reappointed a member of the Virginia Board of Pharmacy. Yi’s appointment will expire on June 30, 2012.

Lydia Main, RPh, • has been reappointed a member of the West Vir-ginia Board of Pharmacy. Main’s appointment will expire on June 30, 2013.

Board Officer ChangesThe Arizona State Board

of Pharmacy has elected the following officers:

Zina Berry, PharmD, •President

Dennis McAllister, •RPh, Vice President

The Idaho State Board of Pharmacy has elected the following officers to the Board:

Dwayne Sheffler, RPh,• Chair

Nicole Chopski, •PharmD, Vice Chair

The Iowa Board of Pharmacy has elected the following officers:

Leman Olson, RPh, •Chair

Vernon Benjamin, RPh, •Vice Chair

The South Carolina Department of Labor, Li-censing, and Regulation – Board of Pharmacy has elected the following officers to the Board:

Davis C. Hook, Jr, RPh,• Chair

Allen Toole, RPh,• Vice Chair

The Tennessee Board of Pharmacy has elected the following officers:

David Todd Bess• , PharmD, President

Bettie K. Wilson, DPh• , Vice President

The Virginia Board of Pharmacy has elected the following officers to the Board:

David C. Kozera, RPh,• Chair

Michael E. Stredler, •RPh, Vice Chair

Around the Association(continued from page 193)

november-december 2008

195*SI = Special Issue

Index Volume 37

2008 NABP Newsletter Index – Volume 37104th Annual Meeting104th Annual Meeting Educational Poster

Session Offers Attendees Opportunity to Earn CPE Credit, Network with Fel-low Members (SI, pg 14)

104th Annual Meeting Educational Ses-sions Tackle Regulation Issues in Phar-macy Practice, Teen Medication Abuse (SI, pg 12)

104th Annual Meeting Offers Opportu-nity to Earn Nine Hours of Continu-ing Pharmacy Education Credit (No. 4, pg 65)

104th Annual Meeting Officer Reports Available Online (SI, pg 2)

104th Annual Meeting Report of Counsel (No. 6, pg 96)

2008 Henry Cade Memorial Award (SI, pg 9)2008 NABP Award Recipients to be Honored

at 104th Annual Meeting (No. 4, pg 66)Annual Meeting Educational Grants and

Sponsors (SI, pg 10)Association Names Award in Honor of

Former NABP Legal Counsel Atkinson (SI, pg 9)

Attendees Discover New Passages to Pro-tecting the Public Health During 104th Annual Meeting (SI, pg 1)

Award Recipients Demonstrate Unwaver-ing Dedication to Protection of Public Health (SI, pg 8)

Baltimore Provides Scenic Backdrop for NABP 104th Annual Meeting Attendees to Network (No. 1, pg 10)

Call for Annual Meeting Poster Session Participants (No. 1, pg 14)

Deadline Set for Advance Distribution of Proposed Resolutions (No. 1, pg 14)

Delegates Approve Eight Resolutions (SI, pg 4)

Federal Regulatory Agencies and Other Organizations Highlight Important Issues and Programs During Educa-tional Table Top Displays (SI, pg 11)

Hospitality Brunch and Educational Table Top Display Offer Participants Chance to Network, Gain Knowledge (No. 2, pg 33)

NABP Annual Meeting Travel Grant En-ables More Board Members to Con-verge, Share Knowledge, Experience (No. 1, pg 13)

NABP Inaugurates Three New Members into Executive Committee to Serve Three-Year Terms Representing Dis-tricts 3, 4, and 8 (No. 6, pg 107)

New Officers, Members Inaugurated Dur-ing 104th Annual Meeting to Serve on NABP 2008-2009 Executive Commit-tee (SI, pg 3)

Optional Events Provide Networking, Op-portunities for Attendees (No. 2, pg 31)

Register Now for the 104th Annual Meet-ing (No. 3, pg 53, No. 4, pg 67)

Register Now for 104th Annual Meeting to Receive Early Rate (No. 2, pg 33)

Registration Begins for NABP 104th An-nual Meeting (No. 1, pg 14)

Senator Tom Daschle to Explore America’s Health Care System at 104th Annual Meeting Keynote Address (No. 3, pg 53)

105th Annual MeetingCall for Posters: Session Participants to Net-

work, Share Information (No. 10, pg 187)Deadline Set for Proposed Amendments

to NABP Constitution and Bylaws (No. 10, pg 186)

NABP Accepting 2009 Award Nominations for 105th Annual Meeting (No. 9, pg 166)

NABP Travel Grant Offered to Defray An-nual Meeting Costs (No. 10, pg 187)

Sponsorship of Educational Grant Opportu-nities Available to Organizations for NABP 105th Annual Meeting (No. 10, pg 186)

Around the AssociationEugene L. “Gene” Argo, NABP Past Presi-

dent, Passes (No. 6, pg 108)Louisiana Board Members Honored (No.

10, pg 189)NABP Appoints Wall to ACPE Board

(No. 6, pg 108)NABP Chairman Peacock Receives Pres-

tigious Harold W. Pratt Award from NACDS for ‘Collaborative Spirit,’ Leadership (No. 9, pg 175)

NABP Donates Bikes to Maryville Acad-emy (No. 10, pg 193)

NABP Inaugurates Three New Members into Executive Committee to Serve Three-Year Terms Representing Dis-tricts 3, 4, and 8 (No. 6, pg 107)

NABP Past President Joseph J. Schwemin Passes (No. 8, pg 154)

Survey Luncheon Drawing Winner (No. 1, pg 16)

Survey Luncheon Winner (No. 10, pg 193)

Board Member Appointments Abeldt, Buford (No. 7, pg 132)Adams, Patrick (No. 1, pg 18)Arceneaux, Mary Kay (No. 9, pg 169)Bamburg, Cynthia (No. 6, pg 106)

Barker, Elizabeth W. (No. 3, pg 54)Boehmer, Timothy (No. 5, pg 86)Boucha, Kathe (No. 7, pg 128)Burgard, James (No. 4, pg 70)Bushardt, Joseph D. (No. 7, pg 132)Calhoun, Donnie (No. 4, pg 70)Calloway, Anika (No. 4, pg 70)Carlson, Dale (No. 8, pg 155)Carr, Terry (No. 1, pg 17)Cartier, Larry (No. 10, pg 194)Casar, Donald M. (No. 9, pg 169)Chow, Stanley (No. 1, pg 18)Collins, Gwenesia (No. 3, pg 54)Cookman, Rebekah (No. 6, pg 106)Croce, John (No. 2, pg 34)Dabney, Gerard (No. 1, pg 17)Dickerhofe, Jeannine G. (No. 2, pg 34)Diehl, Annabelle (No. 10, pg 194)Durand, Sydnie (No. 10, pg 194)Fey, Donald W. (No. 3, pg 54)Galindo, Josephine Anne (No. 5, pg 86)Gonzalez, Fernando (No. 2, pg 34)Hagan, Susan (No. 6, pg 106)Henggeler, Holly (No. 1, pg 17)Hertzfeld, Michael F. (No. 7, pg 128)Hierath, Leonard L. (No. 2, pg 34)Hill, Albert (No. 8, pg 155)Hudson, David C. (No. 9, pg 169)Inguanti, Mary (No. 1, pg 18)Jassey, Stacey (No. 6, pg 106)Kaderly, Barton G. (No. 9, pg 169)Kedron, L. Susan (No. 7, pg 132)Labor, Larry (No. 7, pg 134)Lange, Deborah A. (No. 9, pg 169)Lau, Mary (No. 3, pg 54)Linggi, Albert J. (No. 6, pg 106)Luebke, Chad M. (No. 3, pg 54)Maier, Edward (No. 10, pg 194)Mattila, Amy (No. 6, pg 106)Matens, Richard (No. 10, pg 194)Milovich, Daniel (No. 5, pg 86)Mobley, Hubert (No. 5, pg 86)Moore, Ronald (No. 10, pg 194)Montgomery, Pauline R. (No. 5, pg 86)Olmo Diaz, Maria (No. 8, pg 155)Pearson, Clarence (No. 5, pg 86)Phillips, Pamela J. (No. 7, pg 134)Ramirez, Tomas (No. 8, pg 155)Rivet, Edward (No. 10, pg 194)Simon, Howard I. (No. 7, pg 128)Smith, Charles (No. 1, pg 16)Soileau, Richard “Andy” (No. 10, pg 194)Stephens, Charles (No. 10, pg 194)Trifone, Joanne M. (No. 6, pg 106)Vicente, Migdalia Ruiz (No. 8, pg 155)Walczyk, Stanley B. (No. 7, pg 128)

nabp newsletter

196 *SI = Special Issue

Index Volume 37

Walker-Crawford, Jason D. (No. 7, pg 134)Wallace, Ronald (No. 10, pg 193)Warren, Brenda S. (No. 8, pg 155)Weisner, Dennis (No. 7, pg 132)Weisser, Stanley (No. 5, pg 86)Wheat, Shirley (No. 5, pg 86)White, Jimmy L. (No. 9, pg 169)Williams, Lora (No. 10, pg 194)Wilson, Steve (No. 1, pg 17)Young, Robert (No. 6, pg 99)Ziegler, Gayle (No. 7, pg 132)

Board Member ReappointmentsAbernathy, Gill (No. 10, pg 194)Adams, Patrick (No. 10, pg 194)Arck, Shirley (No. 6, pg 109)Aron, Carl (No. 10, pg 194)Bechtel, Edward J. (No. 1, pg 18)Benjamin, Vernon (No. 6, pg 109)Chater, Rebecca (No. 1, pg 18)Coast, Michael (No. 6, pg 109)Dennis, Betty H. (No. 1, pg 18)Dewhirst, Gary (No. 8, pg 155)Edelblut, E. Katherine (No. 2, pg 34)Fakhoury, Sara (No. 10, pg 194)Gurnsey, Kathleen “Kitty” W. (No. 10, pg

194)Hall, Jacqueline (No. 10, pg 194)Handelman, Mayer (No. 10, pg 194)Howard, Lee (No. 6, pg 109)Howrey, Linda (No. 6, pg 109)Main, Lydia (No. 10, pg 194)Miyamoto, Karl (No. 1, pg 19)McKay, Marty (No. 10, pg 194)Norris, Ronnie (No. 6, pg 109)Osborn, Bill (No. 1, pg 19)Pease, Earl W. (No. 7, pg 134)Pudvah, Emma (No. 7, pg 134)Sheffler, Dwayne (No. 6, pg 109)Strand, Averil (No. 2, pg 35)Wall, Donna S. (No. 10, pg 194)Yi, Brandon K. (No. 10, pg 194)Zweber, Ann (No. 10, pg 194)

Board Officer ChangesArck, Shirley (No. 1, pg 19)Benjamin, Vernon (No. 10, pg 194)Bergrud, Karen J. (No. 6, pg 115)Bernica, Colette (No. 2, pg 35)Berry, Zina (No. 10, pg 194)Bess, David Todd (No. 10, pg 194)Boudreaux, Barry (No. 2, pg 35)Bowersox, George L. (No. 1, pg 19)Brown, Mark E. (No. 1, pg 19)Burgess, Philip (No. 6, pg 109)Carlo, John (No. 2, pg 35)Carr, Terry (No. 8, pg 155)Chesson, J. Parker, Jr (No. 1, pg 19)Chopski, Nicole (No. 10, pg 194)Cloud, James (No. 2, pg 35)

Coast, Mike (No. 1, pg 19)Cover, William (No. 4, pg 70)Dickson, Thomas A. (No. 6, pg 115)Dubose, Clarence (No. 6, pg 115)Fanning, Del (No. 4, pg 70)Farida, Suhair (No. 2, pg 35)Frazer, Berk (No. 6, pg 109)Gardner, Judy (No. 1, pg 19)Gourley, Dorothy Neal (No. 5, pg 86)Hayes, Margaret E. (No. 1, pg 19)Hampton, Diane E. (No. 1, pg 19)Harrop, Randolph A. (No. 8, pg 155)Holm, Richard (No. 4, pg 70)Hook, Davis C. (No. 10, pg 194)Howard, Lee (No. 8, pg 155)Ison, Bobby (No. 1, pg 19)Kozera, David C. (No. 1, pg 19; No. 10, pg 194)Ksiazek, Susan (No. 2, pg 35)Lew, Cathryn J. (No. 6, pg 115; No. 8, pg

155)Manek, Sudhir (No. 6, pg 109)McAllister, Dennis (No. 10, pg 194)McInerney, Gerard (No. 1, pg 19)McManus, Alison K. (No. 8, pg 155)Meredith, Mark (No. 2, pg 35)Mundell, Mary (No. 4, pg 70)Nelson, Wallace E. (No. 1, pg 19)Olson, Leman (No. 10, pg 194)Nolasco, Rudolph (No. 5, pg 86)Petrin, Ronald L. (No. 1, pg 19)Podgurski, Michael (No. 6, pg 115)Romano, Michael (No. 6, pg 115)Sheffler, Dwayne (No. 6, pg 109; No. 10,

pg 194)Smiga, Richard (No. 6, pg 115)Stredler, Michael E. (No. 10, pg 194)Toole, Allen (No. 10, pg 194)White, Dirk (No. 4, pg 70)Wilson, Bettie K. (No. 10, pg 194)Zweber, Ann (No. 6, pg 115)

Executive Director ChangesHuether, Ronald J. (No. 1, pg 16)Martin, Anita O. (No. 10, pg 189)Walker, Mary K. (No. 6, pg 99)

RemembranceArgo, Eugene L. “Gene” (No. 6, pg 108)McLain, Alvin Glen “Mike” (No. 1, pg 16)

Competency Assessment Programs2008-2009 MPJE Review Committee An-

nounced (No. 3, pg 55)December FPGEE Scores Released; June

2008 Date Announced (No. 2, pg 28)FPGEC Certification Process Streamlined;

US Educational Standards Maintained (No. 4, pg 63)

June FPGEE Administration Numbers Re-ported (No. 7, pg 133)

Members of the 2008-2009 NAPLEX Review Committee Announced (No. 4, pg 69)

MPJE State-specific Review Goes Elec-tronic (No. 10, pg 188)

NABP Launches PCOA to Assist Schools, Colleges of Pharmacy in Curriculum Assessment (No. 4, pg 59)

NABP Restores Computerized FPGEE with Increased Security, More Test Sites for Applicants (No. 10, pg 179)

NABP Revisits TOEFL iBT Standards for FPGEC Certification, Convenes Task Force to Assess Findings (No. 8, pg 149)

NABP Seeking ACE Volunteers (No. 9, pg 173)

NABP Seeks Experts for Exam Review Committees (No. 4, pg 62)

NABP Seeks Item Writers for NAPLEX and FPGEE (No. 6, pg 111)

NABP Welcomes Newly Appointed 2008- 2009 ACE Members (No. 6, pg 109)

NAPLEX Item-writing Workshop (No. 1, pg 16)

New 2008-2009 FRC Members Announced (No. 5, pg 84)

PCOA Administered for First Time, 24 Schools and Colleges of Pharmacy Par-ticipate (No. 8, pg 139)

Pre-NAPLEX and NAPLEX Analyses Show Positive Correlation, Practice Exami-nation a Good Predictor for NAPLEX Scores (No. 6, pg 111)

Streamlined Processes Lead to Increase in FPGEE Administrations (No. 2, pg 28)

DMEPOS ProgramCMS Announces DMEPOS Accredita-

tion Deadline for All Suppliers (No. 3, pg 50)

MSAs, Product Categories Announced for Round Two of DMEPOS Competi-tive Bidding (No. 3, pg 51)

NABP Accreditation Programs Thrive in Efforts to Promote Patient Safety (No. 3, pg 38)

NABP Accredits Publix Super Markets, First DMEPOS Accreditation of Super-market Pharmacy (No. 7, pg 119)

Newly Accredited DMEPOS Facilities (No. 1, pg 9; No. 10, pg 188)

Product Categories for Round Two of Competitive Bidding (No. 3, pg 51)

Internet Drug Outlet Identification ProgramInternet Drug Outlets Provide Fertile Ground

for Counterfeits; NABP Lists 562 Sites as ‘Not Recommended’ (No. 7, pg 123)

november-december 2008

197*SI = Special Issue

Index Volume 37

List for Not Recommended Internet Drug Outlets Grows (No. 9, pg 165)

NABP Continues to Report Not Recom-mended Internet Drug Outlets on Asso-ciation Web site (No. 8, pg 155)

NABP Developing Program to Monitor On-line Drug Distributors (No. 3, pg 45)

NABP List of Not Recommended Internet Drug Outlets Grows (No. 10, pg 182)

NABP Names Internet Drug Outlets Op-erating in Conflict with Patient Safety and Pharmacy Practice Standards (No. 6, pg 93)

Legal BriefsAbstention Makes the Board More Im-

muner (No. 1, pg 4)Conviction Set Aside, But Not Far (No.

3, pg 40)Internet, Interstate, International, Inter-

woven (No. 2, pg 24)Liar, Liar, License on Fire? (No. 5, pg 80)Pharmacy SOL (No. 9, pg 160)TAP Dance Revisited (No. 4, pg 60)The Whole is Greater than the Sum of its

Parts (No. 8, pg 140)Unconscionable (No. 7, pg 120)Wholesale Affirmation: Almost (No. 10,

pg 180)

Licensure Transfer ProgramLicensure Transfer Reaches Record Num-

ber of Requests for Ninth Consecutive Year (No. 3, pg 37)

New Internet-based ELTP Application Accelerates Processing, Eliminates In-complete Applications (No. 1, pg 9)

The Backbone of NABP: Streamlined Licensure Transfer Process Contin-ues to Provide Benefits for Boards and Pharmacists (No. 9, pg 171)

NABP – General2008 Annual Report on NABP Legal Af-

fairs (No. 6, pg 95)2008-2009 Committee, Task Force Ap-

pointments Announced (No. 9, pg 163)Beijing Drug Administration, NABP Discuss

Pharmacy Regulation (No. 1, pg 17)Call for Committee and Task Force Vol-

unteers (No. 1, pg 15)E-news Flyer (No. 8, pg 156)NABP Accreditation Programs Thrive in

Efforts to Promote Patient Safety (No. 3, pg 38)

NABP and FDA Meet to Address Public Health Concerns (No. 7, pg 128)

NABP Announces Nominees for 2008-2009 Executive Committee Posts (No. 3, pg 39)

NABP Coordinating Project to Evalu-ate Distribution, Quality of Consumer Medication Information (No. 5, pg 79)

NABP Holds Task Force Meetings (No. 1, pg 15)

NABPLAW Flyer (No. 4, 76)NABPLAW Online Serves as Beneficial Re-

search Tool at Low Cost (No. 8, pg 151)NABP Program Review and Training Famil-

iarizes Board Staff with Association Ini-tiatives, Services (No. 9, pg 169)

NABP Seeks Board Input on Resources and Responsibilities (No. 10, pg 186)

NABP Takes Steps to Curb Diversion, Pollu-tion, Resulting from Improperly Stored, Discarded Medications (No. 10, pg 183)

NABP Task Force Examines Standardization of Medication Container Labels to Aid in Prevention of Errors (No. 10, pg 185)

Surveyors Overcome Brutal Chicago Win-ter to Attend Training (No. 4, pg 69)

Task Force Examines Standard Require-ments for Pharmacy Technicians (No. 9, pg 167)

Task Force Issues Recommendations to Curb Prescription Drug Diversion from Common Carriers (No. 6, pg 102)

Task Force Proposes NABP Accreditation Program to Assist Boards in Uphold-ing Standards for Pharmacy CQI, Peer Review (No. 6, pg 104)

Updated 2009 Survey of Pharmacy Law Now Available (No. 10, pg 184)

Updated Model Act Incorporates Amend-ments Recommended by NABP Com-mittee, Task Forces on Diversion, CQI (No. 8, pg 143)

Pharmacy – GeneralACPE Revises CPE Definition to Specify

Differences in Requirements for Phar-macists and Pharmacy Technicians (No. 7, pg 122)

ACPE Revises Definition of Continuing Education (No. 4, pg 65)

Boards Investigate Regulating Pharma-cies for Patient Care Outcomes to En-sure Quality (No. 8, pg 137)

BTC Drug Class: Exploring a Third Tier in Continued Protection of Public Health (No. 8, pg 144)

California Board of Pharmacy Activates Emergency Response Due to Wildfires (No. 1, pg 3)

California Legislature Extends Deadline for Implementing Track-and-Trace Technology (No. 10, pg 189)

Community Pharmacy Accreditation Shown to Improve Patient Care, Reduce Medication Error (No. 10, pg 177)

CPE Standards Revised to Better Meet the Needs of Pharmacists and Phar-macy Technicians (No. 6, pg 110)

DEA Form 106 Now Available Online (No. 6, pg 103)

FDA’s ANDA Review Process Designed to Ensure Safety and Efficacy of New Ge-neric Medications (No. 6, pg 100)

Federal Legislation Proposed (No. 9, pg 168)Generic Substitution Raises Questions,

Concerns for Some Patient Groups (No. 2, pg 26)

Health Information Technology Advances (No. 5, pg 77)

Internet Drug Distributors Posing New Concerns (No. 3, pg 42)

New Act Seeks to Streamline Emergency Response (No. 1, pg 1)

NPI Contigency Deadline Approaches (No. 5, pg 83)

Prescription Medication Counterfeiters Continue to Exploit Internet, Expand Globally (No. 9, pg 157)

Preventing Medication Errors from Pre-scribing to Dispensing, Restoring the Worth of Cure (No. 7, pg 117)

Record Number of Electronic Prescrip-tions Routed in 2007; More Expected in 2008 (No. 7, pg 124)

Rx Response Supports Continued Deliv-ery of Needed Medicines in Emergen-cies (No. 10, pg 193)

Standardized Medication Container La-bels Touted as Prescription for Patient Safety (No. 3, pg 48)

States Adjust Pain Medication Policies to Balance Patient Access, Regulatory Control (No. 2, pg 21)

State, Federal Regulatory Authorities Combat Rogue Internet Drug Distrib-utors (No. 4, pg 57)

Sterile Compounding “Checklist” Revised to Better Protect Patient Health; New USP Chapter Effective June 2008 (No. 2, pg 29)

Studies Show Increased Methadone-Associated Mortality Related to Pain Management (No. 1, pg 6)

PhotosAdams, Joseph L. (No. 1, pg 15)Anderson, Howard C., Jr (No. 1, pg 15)Anderson, Wendy L. (No. 1, pg 15; No.

10, pg 192)Argo, Eugene L. “Gene” (No. 6, pg 108)Aron, Carl W. (No. 3, pg 55)Atkinson, Dale J. (No. 1, pg 5; No. 2, pg

25; No. 3, pg 41; No. 4, pg 61; No. 5, pg 81; No. 6, pg 97; No. 7, pg 121; No. 8, pg 141; No. 9, pg 161, No. 10, pg 181)

nabp newsletter

198 *SI = Special Issue

Index Volume 37

Atkinson, John F. (SI, pg 9)Baran, Rosalie (No. 1, pg 16)Barr, Charles Curtis “Curt” (SI, pg 8)Bauer, Phil (SI, pg 12)Bender, Thomas (No. 10, pg 188)Benjamin, Vernon H. (No. 1, pg 15)Bernstein, Ilisa (SI, pg 12)Bess, David Todd (No. 9, pg 176)Bolin, Joshua M. (SI, pg 12)Borcher, Kevin C. (No. 3, pg 55; No. 10,

pg 188)Braylock, Gregory Sr (No. 6, pg 107; SI, pg

6, 16; No. 10, pg 192)Broussard, Malcolm J. (SI, pg 7, 12)Buesing, Amy S. (No. 1, pg 15)Bundrick, Lee Ann (No. 3, pg 55; No. 10,

pg 192)Burgess, Phil (No. 10, pg 188)Burleson, Michael A. (No. 3, pg 55; No. 6,

pg 107; SI, pg 6, 13)Burns, Anne (No. 10, pg 188)Caldwell, Kim (No. 1, pg 15; No. 10, pg 188)Campbell, Jay (No. 1, pg 15)Catizone, Carmen A. (No. 1, pg 17)Corrigan, Melissa Murer (SI, pg 11; No. 10,

pg 192)Darvey, Diane (No. 10, pg 188)Daschle, Tom (No. 3, pg 53; SI, pg 16)Delaney, Barbara (SI, pg 12)DeVita, James T. (No. 1, pg 15; No. 10, pg

188)Dilliard, Reggie (No. 3, pg 55; SI, pg 16)Dodson, Gay (No. 10, pg 192)Dong, Betty J. (No. 9, pg 176)Dorvee, John R., Jr (No. 1, pg 15)Dryden, David W. (No. 3, pg 55)Duteau, Michael (No. 9, pg 176)Eidson, Kevin K. (No. 5, pg 91; SI, pg 16)Fitzpatrick, Cynthia P. (SI, pg 11)Fitzpatrick, William “Bill” (No. 10, pg 188)Fitzwater, Ron (No. 10, pg 188)Flynn, Arlene (No. 10, pg 188)Frank, Courtney (No. 9, pg 169)Fry, W. Benjamin (No. 10, pg 188)Gaither, Patricia (SI, pg 11)Gardner, Judy (No. 5, pg 92)Gibbons, Moira (No. 1, pg 17)Gluck, Benjamin N. (SI, pg 13)Goodman, Summar (SI, pg 11)Goodmaster, Edith G. “Edie” (No. 1, pg 15)Gross, Stephen M. (No. 5, pg 92)Grubbs, George T. (SI, pg 8)Hall, Jacqueline (No. 10, pg 192)Harvey, William (No. 1, pg 15)Hedrick, Thomas A. (SI, pg 12)Herold, Virginia “Giny” (SI, pg 14)Houchens, Tom M. (No. 1, pg 16; No. 5,

pg 92; SI, pg 9; No. 9, pg 176)

Huether, Ronald J. (No. 5, pg 91)Jacknowitz, Arthur I. (No. 5, pg 92; SI, pg

9; No. 9, pg 176)Jessen, Lloyd K. (No. 1, pg 15; SI, pg 7)Johnson, Jeane (No. 10, pg 192)Johnston, Mark D. (No. 5, pg 91)Kehoe, William (No. 1, pg 16)Keresztes, Jan (No. 10, pg 192)King, Stephen (SI, pg 11)Kittrell, Gwen (SI, pg 11)Klein, Ronald J. (No. 5, pg 91; No. 6, pg 115)Knutsen, Randall (No. 1, pg 15)Koh-Knox, Cynthia P. (No. 6, pg 114)Ksiazek, Susan (No. 3, pg 55; No. 10, pg 192)Lew, Cathryn J. (SI, pg 7, 12, 16; No. 10,

pg 188)Lewalski, Eileen (SI, pg 12)Liang, Hong (No. 1, pg 17)Limberis, Paul N. (No. 1, pg 15; No. 10,

pg 188)Lord, Mandy (SI, pg 11)Lynch, Kendall M. (No. 5, pg 92; SI, pg 16;

No. 9, pg 176)Markuson, Richard K. “Mick” (No. 9, pg 176)Marshall, Robert (No. 10, pg 188)Matthews-Lopez, Joy (No. 1, pg 16)McGinley, Edward G. (No. 1, pg 15)Mendoza, Alice (No. 1, pg 15)Miller, Ruth K. (SI, pg 13)Mitchell, Kevin J. (No. 1, pg 15; No. 10, pg 188)Mokhiber, Lawrence H. “Larry” (No. 10,

pg 188) Moore, Kristin (No. 9, pg 169)Morrison, Richard “Dick” (No. 9, pg 176)Morse, Steve (No. 6, pg 115)Murer-Corrigan, Melissa (SI, pg 11)Naesea, LaVerne G. (SI, pg 11)Nicholson, Kevin (No. 10, pg 192)Okeke, Claudia C. (SI, pg 13)Orzali, Peter J., Jr (No. 1, pg 15)Palombo, Rich (No. 1, pg 15; SI, pg 3, 9, 13)Parham, Cindy (No. 9, pg 169)Pasquale, Heather Lee (No. 3, pg 55)Peacock, Oren M., Jr (No. 5, pg 91; SI, pg

3, 8; No. 9, pg 175; No. 10, pg 188)Podgurski, Michael A. (No. 3, pg 55; No.

10, pg 188)Policastri, Anne (No. 10, pg 188)Poston, Rebecca R. (No. 1, pg 15)Potter, Bryan H. (SI, pg 8)Pray, W. Steven (SI, pg 9)Riccio, Krystal (SI, pg 15)Rigelsky, Janene M. (No. 1, pg 16)Roll, David B. (SI, pg 9)Russell, Elizabeth Scott “Scotti” (SI, pg 6, 13)Ryle, Karen M. (SI, pg 6, 12; No. 9, pg 176)Rynn, Kevin (No. 9, pg 176)Saxe, Steven M. (SI, pg 16)

Schnabel, Gary A. (SI, pg 3)Sheckelhoff, Douglas (No. 10, pg 192)Sieck, Cynthia (No. 6, pg 114)St. Angelo, Sara (No. 10, pg 188)Summers, Kent (No. 10, pg 188)Teeters, Janet (No. 10, pg 188)Toole, Ryan (SI, pg 12)Van Horne, Barbara A. (SI, pg 11)Vlasses, Peter (No. 10, pg 188)Waggener, Jeanne (No. 10, pg 188)Wall, Donna S. (No. 6, pg 108)Walker, Mary K. (No. 3, pg 55; No. 5, pg 91)Walker, Neil F. (No. 6, pg 114)Wand, Hal (No. 6, pg 107; SI, pg 7)Warren, Brenda S. (SI, pg 16)Weinstock, Jason (SI, pg 13)Winsley, William T. “Bill” (SI, pg 6, 13)Whitchurch, Frank A. (No. 1, pg 15)Young, Charles R. “Chuck” (No. 1, pg 15)Zweber, Anne (SI, pg 15)

Professional Affairs UpdateAMA Issues Policy on Unapproved Com-

pounded Medications (No. 6, pg 112)Appellate Court Ruling Upholds Injunction of

FDA Pedigree Rule (No. 10, pg 190)ASCP Issues Guidelines on Medical Infor-

mation for the Blind (No. 5, pg 86)California Awareness Project Aims to Divert

Pharmaceuticals from Water Supply (No. 10, pg 190)

Clarification Sets Apart Two OTC Product Rules (No. 4, pg 70)

Coalition Looks to Pharmacies, Regulators to Reduce Drug Diversion (No. 7, pg 129)

DEA Proposes New Order Form for Con-trolled Substances (No. 3, pg 54)

DEA Proposes Rule for e-Prescribing of Con-trolled Substances (No. 8, pg 154)

DEA Rule Allows Multiple Rxs for Con-trolled Meds (No. 2, pg 34)

District Court Ruling Overturned in Phar-macy Compounding Case (No. 9, pg 173)

DME Sellers Convicted for Medicare Fraud (No. 4, pg 70)

FDA Acts to Ensure Thyroid Drugs Maintain Potency until Expiration Date (No. 1, pg 19)

FDA Embarks on Major Hiring Initiative to Strengthen Its Public Health Mission (No. 10, pg 190)

FDA Encourages Boards to Use FDA Patient Safety News (No. 7, pg 129)

FDA Issues Adverse Event Reporting Rules for OTC Products (No. 3, pg 54)

FDA Names Products Requiring Risk Evalu-ation, Mitigation Strategy (No. 6, pg 112)

FDA Plans to Set up Shop Abroad (No. 4, pg 70)

november-december 2008

199*SI = Special Issue

Index Volume 37

FDA Proposes Guidance on Reprint Prac-tices (No. 5, pg 85)

FDA Study: Meds Sought Online to Avoid Rx Rules (No. 1, pg 18)

FDA Takes Action against Companies Mar-keting Unapproved Injectable Colchicine (No. 9, pg 173)

FDA Takes Action against Compounded BHRT Drugs (No. 4, pg 71)

FDA Takes Next Step to Establish Permanent Offices in China (No. 6, pg 112)

FDA Targets Sales of Unapproved Hydro-codone Products (No. 2, pg 34)

Fentanyl Pain Patches Recalled Due to Risk from Cut Edge (No. 5, pg 86)

FSMB Mulls Model Policy on Continuing Competence for Relicensure (No. 7, pg 129)

Google Launches Online Medical Records Service (No. 6, pg 112)

HHS Proposes Patient Safety Reporting Rule (No. 5, pg 85)

IL, WI Adopt Laws to Protect Rx Distribu-tion Systems (No. 1, pg 18)

Joint Commission Reports on Pediatric Medication Errors (No. 7, pg 129)

London Court Blocks Eli Lilly’s Efforts to Stop Re-importation of its Drugs (No. 5, pg 86)

Manufacturers Agree to Restrict Distribu-tion of Methadone (No. 3, pg 54)

Medicaid Tamper-Proof Prescription Pad Rule in Effect (No. 5, pg 85)

Medicare Pilot Project Nears End (No. 4, pg 70)

NABP Staff Discuss Technician Regulations at ASHP Meeting (No. 3, pg 54)

NABP Testifies in Support of Proposed BTC Class of Drugs (No. 1, pg 18)

Popularity of Mail-Order Pharmacies In-creases (No. 5, pg 85)

Proposed Law Would Mandate E-Prescrip-tions (No. 5, pg 85)

Proposed Rule Modifies Combat Meth Act (No. 1, pg 19)

Senate Passes Bill to Restrict Distribution of Controlled Substances Online (No. 6, pg 112)

Study Fuels Concerns over Foreign Drugs Purchased Online (No. 7, pg 129)

Study Highlights Continued Prevalence of Rogue Internet Drug Outlets (No. 9, pg 173)

Switch to HFA-Propelled Albuterol Inhalers Advised Prior to CFC Ban (No. 8, pg 154)

Uniform Standards for e-Prescribing (No. 2, pg 34)

US House Passes Dextromethorphan Distri-bution Act (No. 1, pg 18)

RetractionsClarification (No. 4, pg 62)

State Board NewsAlaska Considers CS Prescription Monitor-

ing Program (No. 4, pg 72)Arkansas Board Adopts Practitioner-Patient

Relationship Regulation (No. 7, pg 131)Arizona Adopts New CS Prescription Moni-

toring Program (No. 4, pg 72)AZ CS Prescription Monitoring Program

Forges Ahead (No. 9, pg 174)Bill Would Give WV Board Authority over

Clinics (No. 5, pg 87)California Passes Law on Standardized Rx

Medication Labeling (No. 2, pg 35)DC Board Mandates Valid Patient-Practitio-

ner Relationship (No. 5, pg 87)DC Enacts SafeRx Law; Rules in Works (No.

7, pg 131)Florida Passes Bill Requiring Registration of

Technicians (No. 6, pg 113)Hawaii Adopts Law Allowing Importation of

Foreign Drugs (No. 6, pg 113)IA Board Provides Update on Internet Drug –

MyPharma.com (No. 7, pg 131)IN Passes Legislation Requiring VIPPS Ac-

creditation (No. 5, pg 88)Iowa Board Proposes Mandatory Certifi-

cation for Pharmacy Technicians (No. 4, pg 72)

Iowa Board Publishes New Pharmacy Technician Rules (No. 10, pg 191)

Kansas Board Recaps 2008 Legislative Changes (No. 8, pg 152)

LA Board Approves Collaborative Drug Ther-apy Management Rule (No. 6, pg 113)

LA Board Proposes New Chapter for Con-trolled Dangerous Substances Regulation (No. 9, pg 174)

Louisiana Board Requires CPE to Include Live Presentations (No. 4, pg 72)

MD Passes Legislation for Comprehensive PBM Oversight (No. 6, pg 114)

Medication Error Reporting Notice Required in Delaware Pharmacies (No. 8, pg 152)

Minnesota Adopts Law to Thwart Illicit In-ternet Drug Outlets (No. 6, pg 113)

MN Disciplines Pharmacists for Dispens-ing Illegal Internet Prescriptions (No. 10, pg 192)

Nevada Board Now Reciprocates with All Other States (No. 9, pg 174)

New Jersey Adopts Must-Fill Law (No. 4, pg 72)

New Jersey Announces Online Registration Application for Out-of-State Pharmacies (No. 9, pg 174)

New Legislation Requires Pharmacy Technician Registration in Kentucky (No. 10, pg 192)

North Carolina Board Implements New CPE Requirements (No. 4, pg 73)

OH Board Warns Pharmacists of Internet Scams (No. 5, pg 87)

Pharmacist Administration of Vaccinations, Immunizations Proposed (No. 5, pg 87)

Pharmacists Warned Against Dispensing Il-legitimate Internet Prescriptions (No. 7, pg 131)

Prescription Drug Monitoring Program Now Live in Colorado (No. 10, pg 191)

Rules Described for Physician Assistant Pre-scribing in Ohio (No. 7, pg 132)

SC Board Implements Educational Require-ments for Compounding Staff (No. 7, pg 132)

State Certification Process Approved for SC Technicians (No. 10, pg 191)

South Dakota Board Developing Telephar- macy Rules (No. 4, pg 73)

VA Board Passes New Requirements for Non-resident Pharmacies (No. 10, pg 191)

VA Prescription Monitoring Program Ex-pands in 2007 (No. 5, pg 88)

WA Board Adopts Pharmacy Technician Standardized Examination Requirement (No. 9, pg 174)

WA Board Adopts Rule for Reporting Suspi-cious PSE Transactions (No.2, pg 35)

WA Methamphetamine Work Group Says Logs Successful (No. 6, pg 113)

Washington Implements New Naturopathy Rules (No. 4, pg 73)

WV Law Allows Pharmacists to Give Immu-nizations (No. 6, pg 114)

SymposiumNABP Symposium to Address Counter-

feit Drugs, BTC Class (No. 8, pg 147)NABP 2008 Symposium to Provide Lively

Forum in Breathtaking Tucson (No. 7, pg 126)

Qigong: An Invigorating Way to Start the Day (No. 7, pg 126)

Save the Date (No. 6, pg 94)2008 Symposium Schedule (No. 9, pg 170)

VAWD ProgramNABP Accreditation Programs Thrive in

Efforts to Promote Patient Safety (No. 3, pg 38)

Newly accredited VAWD facilities (No. 1, pg 8; No. 2, pg 36; No. 3, pg 55; No. 4, pg 71; No. 5, pg 83; No. 6, pg 116; No. 7, pg 135; No. 8, pg 152; No. 10, pg 191)

VAWD Surety Bond Requirements Up-dated (No. 8, pg 148)

VIPPS ProgramNABP Accreditation Programs Thrive in

Efforts to Promote Patient Safety (No. 3, pg 38)

november-december 2008nabp newsletter

National Association of Boards of Pharmacy

1600 Feehanville Drive

Mount Prospect, IL 60056

nabp newsletter

Association Highlights

Save the Date!NABP 105th Annual Meeting May 16-19, 2009 Hyatt Regency Miami Miami, FL

The NABP Annual Meeting offers attendees the opportunity to assist in shaping the future direction of NABP through their participation in important business sessions during which officers and members of the NABP Executive Committee are elected. In addition, the meeting provides Accreditation Council for Pharmacy Education-approved continuing pharmacy edu-cation programs and networking opportunities. More information will be available in future is-sues of the NABP Newsletter and on the Meetings section of the NABP Web site at www.nabp.net.

NABP:M I A M I

Quality Care.It’s Hot! Hot! Hot!